News

Find News

Filter articles

Applied Filters

Showing 81 to 90 of 957 results

Has the public got the taste for free medicine?

International05-06-2020Rory O'Neill

The COVID-19 pandemic has seen the fundamental principles of the IP system called into question. How can we go on as before?

AG advises CJEU to uphold €94 million pay-for-delay fine

EU05-06-2020Sarah Morgan

The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme. 

English court gives Mylan green-light to sell generic insomnia drug

UK04-06-2020Sarah Morgan

In a victory for Mylan, the English High Court has rejected Israel-based pharmaceutical company Neurim’s attempt to delay a generic version of its insomnia medication.

Teva to face inhaler infringement allegations in UK court

UK03-06-2020Rory O'Neill

Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.

FDA warns of ‘grave’ knock-on effects from Eagle decision

US29-05-2020Rory O'Neill

The US Food and Drug Administration has warned a US Court of Appeals for the DC Circuit decision awarding market exclusivity to Eagle Pharmaceuticals for a cancer drug will have “grave” consequences for patient access.

FDA approves Hikma’s Vascepa generic

26-05-2020Rory O'Neill

London-based Hikma Pharmaceuticals has won approval to launch the first generic version of Vascepa, after having key Amarin patents for the heart drug invalidated.

Gilead agrees 127-country remdesivir licence with generic makers

International14-05-2020Rory O'Neill

Gilead has agreed to license its antiviral remdesivir to five generic makers for distribution during the COVID-19 pandemic.

US judge dismisses attorney’s ‘opportunistic’ whistleblower suit

US14-05-2020Sarah Morgan

A Californian judge has thrown out an attorney’s whistleblower lawsuit alleging Bausch Health Companies fraudulently obtained a patent for its ulcerative colitis drug Apriso.

Fed Circuit affirms generic maker’s win over Eagle

US11-05-2020Sarah Morgan

The US Court of Appeals for the Federal Circuit has affirmed a generic maker’s victory over pharmaceutical company Eagle Pharmaceuticals in a case involving cancer drug Belrapzo.

Bausch Health resolves IBS patent litigation

US07-05-2020Sarah Morgan

Canada-based Bausch Health has agreed to settle its dispute with generic maker Sandoz over the latter’s attempt to release a generic version of antibiotic Xifaxan.

Showing 81 to 90 of 957 results

LSIPR